The New “Black Gold” – Georgiadis on Greece as a Global Health Hub
At the 5th Metropolitan Economist Conference, the Minister of Health presented the digital revolution, €1.6 billion in investments, and an AI strategy.
ΣΑΒΒΑΤΟ
06
ΣΕΠΤΕΜΒΡΙΟΥ
LEO PHARMA
Ειδήσεις, video, ειδησεις τωρα και νέα για LEO PHARMA από το pagenews.gr
-
The New “Black Gold” – Georgiadis on Greece as a Global Health Hub -
Piraeus Bank Transfers 850 ATMs to Cashflex, Introduces New Withdrawal Fees
Piraeus Bank Transfers 850 ATMs to Cashflex, Introduces New Withdrawal Fees
These 850 ATMs will now charge a €2.10 fee per cash withdrawal, with €0.60 going to Piraeus Bank and €1.50 to Cashflex. Customers who check their account balance at these ATMs will face an additional €1.50 fee.
-
UBS Ranks Greece Among Most Vulnerable to Trump’s US Tariffs
UBS Ranks Greece Among Most Vulnerable to Trump’s US Tariffs
UBS identifies Greece as one of the three European countries most exposed to the new tariff regime, based on the share of its exports to the US affected. These exports span sectors where Greece excels, including chemicals, pharmaceuticals, agricultural products, and processed industrial goods. Notably, the proposed tariffs offer no exemptions or tiered rates.
-
Greek Budget Surplus Reaches €4.6 Billion in First Half of 2025
Greek Budget Surplus Reaches €4.6 Billion in First Half of 2025
Tax Revenue Performance in the State Budget
-
Kimberly Guilfoyle: Greece is a pillar of stability and a staunch NATO ally
Kimberly Guilfoyle: Greece is a pillar of stability and a staunch NATO ally
The ambassador nominee underlined Greece's critical role in NATO's southern flank, making special reference to the strong defense ties between the US and Greece and to the fact that Greece is one of the countries most consistently fulfilling its obligations in the alliance related to defense expenditures.
-
Ανταγωνισμός για Novo Nordisk και Eli Lilly –Οι Κινέζοι μπαίνουν στην αγορά των φαρμάκων κατά της παχυσαρκίας
Ανταγωνισμός για Novo Nordisk και Eli Lilly – Οι Κινέζοι μπαίνουν στην αγορά των φαρμάκων κατά της παχυσαρκίας
Η κινεζική εταιρεία Innovent Biologics εξασφάλισε την περασμένη εβδομάδα άδεια για το φάρμακο mazdutide, με το Bloomberg να μιλά για ένα σημείο καμπής στις προσπάθειες της Κίνας να καταπολεμήσει την αύξηση των ποσοστών παχυσαρκίας και διαβήτη με δικές της καινοτομίες.
